What workup is indicated for a patient with marked transaminitis (elevated aspartate aminotransferase and alanine aminotransferase), normal abdominal computed tomography and abdominal ultrasound, left upper quadrant pain, and unintentional weight loss?

Workup for Marked Transaminitis with Normal Imaging

This patient requires comprehensive serologic testing and Doppler ultrasound to evaluate for hepatocellular injury causes, followed by consideration of CT abdomen/pelvis with IV contrast if initial workup is unrevealing, given the moderate-to-severe aminotransferase elevation (>10x normal) combined with concerning symptoms of weight loss and abdominal pain.

Classification and Urgency

Your patient has moderate-to-severe transaminitis (AST 436, ALT 416 = approximately 10x upper limit of normal), which warrants a more expeditious evaluation than mild elevations 1. The combination of marked enzyme elevation, left upper quadrant pain, and unintentional weight loss raises concern for serious underlying pathology despite normal initial imaging.

Recommended Diagnostic Algorithm

Initial Serologic Workup (Priority)

Based on the hepatocellular pattern of injury (aminotransferases elevated disproportionately to alkaline phosphatase), the following tests are essential 2, 1:

Common causes to exclude first:

• Hepatitis A IgM, Hepatitis B surface antigen, Hepatitis C antibody
• Comprehensive medication/supplement review (including over-the-counter, herbal products)
• Alcohol use assessment (AST:ALT ratio >2 suggests alcoholic liver disease; <1 suggests metabolic disease) 1
• Fasting glucose or HbA1c, lipid panel, and metabolic syndrome assessment
• Complete blood count with platelets
• Serum albumin and prothrombin time/INR (to assess synthetic function)

Uncommon but important causes:

• Iron studies (serum iron, total iron-binding capacity, ferritin) for hereditary hemochromatosis 3
• Ceruloplasmin and 24-hour urine copper (if age <40 years) for Wilson disease 2
• Antinuclear antibody, anti-smooth muscle antibody, anti-liver-kidney microsomal antibody for autoimmune hepatitis 2
• Alpha-1-antitrypsin level and phenotype 3

Given the weight loss and abdominal pain, also consider:

• Serum IgG4 level (IgG4-related disease can present with abdominal pain, weight loss, and transaminitis) 4
• Thyroid function tests (extrahepatic cause) 3
• Creatine kinase (to exclude muscle source of AST elevation) 2

Advanced Imaging (Next Step)

Since routine CT and ultrasound were normal but you have moderate-to-severe elevation, additional imaging is indicated 1:

US Duplex Doppler abdomen is complementary and usually appropriate to evaluate:

• Hepatic vascular flow (Budd-Chiari syndrome, portal vein thrombosis)
• Ischemic hepatitis (a common cause of severe transaminitis in critically ill patients) 1, 5

CT abdomen/pelvis with IV contrast should be obtained if initial serologies are unrevealing because 1:

• It can identify ischemic liver injury, hepatic congestion, and vascular abnormalities
• Superior for detecting lymphadenopathy (relevant given weight loss)
• Can identify pancreaticobiliary pathology that may have been missed on initial imaging 6

Critical Pitfalls to Avoid

1. Don't assume cholecystectomy excludes biliary pathology: Recurrent choledocholithiasis can cause severe transaminitis even years post-cholecystectomy 6. If there's any CBD dilation on imaging, proceed to ERCP.

2. Don't rely solely on acetaminophen levels: Repeated supratherapeutic ingestion can cause severe hepatocellular injury with undetectable serum levels 7. Obtain detailed ingestion history.

3. Don't overlook non-hepatitis viral causes in appropriate contexts: Co-infections (EBV, dengue, CMV) can cause severe transaminitis, especially with systemic symptoms 8.

4. Weight loss is a red flag: This symptom combined with transaminitis should prompt consideration of infiltrative processes, malignancy, or systemic inflammatory conditions like IgG4-related disease 4.

Follow-up Strategy

If initial comprehensive workup is unremarkable and patient remains symptomatic or enzymes persist elevated:

• Liver biopsy is indicated for chronic elevation (>6 months) or when diagnosis cannot be established non-invasively 2, 9
• Serial monitoring of liver chemistries is essential if observation is chosen 2
• Consider MRI abdomen without contrast for superior steatosis detection if NAFLD is suspected but needs confirmation 1

The presence of normal albumin and prothrombin time is reassuring regarding synthetic function, but doesn't exclude significant underlying disease requiring diagnosis 2.